Kura Biotech

Executive Summary

Kura Biotech is a privately held, commercial-stage biotechnology company based in Santiago, Chile, specializing in the development and manufacturing of recombinant proteins, enzymes, and antibodies for research, diagnostic, and therapeutic applications. Founded in 2006, the company has established itself as a key supplier in the life sciences tools sector, leveraging cost-effective production capabilities and a robust portfolio of high-quality reagents. With a focus on proteomics and diagnostics, Kura Biotech serves both academic and industrial customers, offering custom and catalog products that support a wide range of assays and drug discovery workflows. The company's strategic location in Chile provides access to skilled talent and competitive operational costs, positioning it well for growth in the expanding global market for biologics and diagnostic components. While Kura Biotech operates outside the major biotech hubs, its specialized offerings and reliable supply chain have earned it a niche reputation, particularly in Latin America and emerging markets. The company continues to invest in R&D to expand its product line and address unmet needs in infectious disease diagnostics and immunotherapy research.

Upcoming Catalysts (preview)

• Q3 2026Launch of new recombinant protein for infectious disease diagnostics70% success
• TBDStrategic partnership with a major diagnostics company for co-development50% success
• Q3 2026Expansion of manufacturing capacity in Santiago to meet growing demand80% success